Get Quote

Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Game Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

1
Member Avatar bsmith47 (45.03) Submitted: 17/04/2008 11:41:07 : Outperform Start Price: $6.74 ARRY Score: -40.62

biotech darling will be bought out eventually by a big pharma for growth.

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.